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Micropatterning of TCR and LFA-1 ligands reveals
complementary eﬀects on cytoskeleton
mechanics in T cells†
Erdem Tabdanov,a Sasha Gondarenko,b Sudha Kumari,c Anastasia Liapis,c
Michael L. Dustin,cd Michael P. Sheetz,ef Lance C. Kam*a and Thomas Iskratsch‡*e
The formation of the immunological synapse between a T cell and the antigen-presenting cell (APC) is
critically dependent on actin dynamics, downstream of T cell receptor (TCR) and integrin (LFA-1) signalling.
There is also accumulating evidence that mechanical forces, generated by actin polymerization and/or
myosin contractility regulate T cell signalling. Because both receptor pathways are intertwined, their
contributions towards the cytoskeletal organization remain elusive. Here, we identify the specific roles of
TCR and LFA-1 by using a combination of micropatterning to spatially separate signalling systems and
nanopillar arrays for high-precision analysis of cellular forces. We identify that Arp2/3 acts downstream of
TCRs to nucleate dense actin foci but propagation of the network requires LFA-1 and the formin FHOD1.
LFA-1 adhesion enhances actomyosin forces, which in turn modulate actin assembly downstream of the
TCR. Together our data shows a mechanically cooperative system through which ligands presented by an
APC modulate T cell activation.
Insight, innovation, integration
Development of tools to measure or apply forces resulted in our current knowledge of the mechano-regulation of cellular processes. It is increasingly important to
understand how diﬀerent receptor pathways interact with each other to influence the mechano-signalling. We focus here on the specific example of how TCR and
LFA-1 interact in the context of the immunological synapse in T cells; augmentation of TCR signalling by LFA-1 provides eﬃcient activation of these cells and the
immune response. Microcontact printing of TCR and LFA-1 ligands revealed the specific contributions to the activation of actin assembly and generation of tensile
forces. In conjunction with micropillar arrays used to quantify the cellular forces, we provide an integrative model of immune synapse formation.
Introduction
T cell activation, a key regulatory point of the adaptive immune
response, is initiated by engagement of an antigen presenting cell
(APC) and formation of an immune synapse (IS) which focuses
communication between these cells. Establishment of this
specialized interface involves multiple membrane-associated
signalling systems; binding of T cell receptor (TCR) to peptide-
loaded major histocompatibility complex (pMHC) and Lympho-
cyte function-associated antigen 1 (LFA-1) to Intercellular cell
adhesion molecule-1 (ICAM-1), which provide antigen-dependent
activation and long-lasting cell–cell adhesion respectively,
represents a minimalist set of signals that promote functional
activation.1–5 In addition to molecular cues, it is increasingly
clear that mechanical forces have important roles in IS signalling.
Early studies demonstrated that the T cell cytoskeleton is important
for formation of TCR- and LFA-1-containing microclusters along
the distal edge of the expanding interface and their subsequent
reorganization into the central- and peripheral-supramolecular
activation clusters (cSMAC and pSMAC) that define the arche-
typal IS.6–9 Restricting centripetal motion of microclusters
enhances early TCR signalling,10,11 potentially by delaying sorting
of TCR into extracellular microvesicles at the cSMAC,12,13 suggesting
that the response of the extracellular environment to cellular
forces can modulate IS function. This concept is further sup-
ported by studies showing that cell activation is sensitive to the
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mechanical stiffness of a stimulatory substrate presenting
ligands to CD3 and CD28,14,15 indicating a functional role of
mechanosensing in T cell physiology.
The cytoskeleton thus provides a mechanical platform for IS
signalling, and understanding the factors that modulate this
structure is critical for a complete model of T cell function. It is
attractive to consider LFA-1 as the primary link between the
cytoskeleton and extracellular environment, similar to the role
that other integrins provide for adherent cells.16 However, LFA-1
signalling within the immune synapse is complex and intertwined
with TCR signalling;17,18 full activation of LFA-1 is initiated by TCR
function.17 Moreover, rigidity sensing is mediated by CD3 in
the context of CD28 co-stimulation14 and TCR signalling leads to
actin polymerization,5,19 suggesting direct, mechanical roles of this
receptor. Clear delineation of how TCR and LFA-1 modulate
cytoskeletal dynamics has been diﬃcult since ligands to these
receptors are normally presented to cells uniformly distributed
across an activating surface. Micropatterning of surfaces with
ligands to the TCR complex and LFA-1 has emerged as a powerful
strategy for interrogating how IS structure influences intra-IS
signalling.20–23 In this report, we use micropatterned surfaces
and elastomer nanopillar arrays (in a traction force microscopy
mode7,24) to delineate the specific roles of the TCR complex and
LFA-1 in modulating the mechanics of the T cell cytoskeleton.
Thereby, we find a separation of functions for both receptor
systems that extend to a specification of actin assembly pathways.
Actin nucleation downstream of TCR enables the actin network
extension downstream of LFA-1, which provides the cytoskeletal
tension to allow mechanical sensing, T cell spreading and
to enhance TCR activation. Together our data provide new
mechanistic insights into the processes that lead to the IS
formation and T cell activation.
Results
TCR and LFA-1 have complementary roles in cytoskeleton
anchorage and contractility
The dependence on both TCR and LFA-1 for promoting stable T
cell interfaces is illustrated in Fig. 1. Primary human CD4+ T
cells seeded on surfaces coated with a mix of OKT3 (an antibody
that activates the TCR complex CD3e chain) and ICAM-1
(hICAM-1-Fc, a fusion of the ICAM-1 extracellular domain with
Fc, both present at the interface at comparable densities,
Fig. S1A (ESI†)) exhibit extensive spreading with both actin
and myosin IIa (basic molecular machinery for cytoskeletal
contractility) present across the cell–substrate interface
(Fig. 1A, left panel). Local enrichment of these proteins along
the cell edge indicates that these primary cells develop lamella
and lamellipodia structures (Fig. S2, ESI†), similar to T cell
blasts and Jurkat cells.2,3,25 Cells on surfaces coated with OKT3
alone are more rounded with only thin, dendritic processes at
the same 30 minute time point (Fig. 1A, right panel, Fig. S2,
ESI†), while substrates presenting ICAM-1 alone do not support
significant adhesion (data not shown). Tyrosine phosphoryla-
tion (as a measure for early T cell activation) on rigid surfaces
(Sylgard 184, B2 MPa) coated with OKT3 and ICAM-1 was
higher than on surfaces coated with OKT3 alone, indicating that
engagement of LFA-1/ICAM-1 increases the level of TCR trigger-
ing (Fig. 1B) compared to the engagement of TCR/OKT3 alone.
Moreover, similar to previous reports,14 a comparison between
soft (Sylgard 527,B5 kPa)26 and rigid substrates (Sylgard 184), as
well as blebbistatin treated cells indicated that TCR triggering
depended on substrate compliance as well as the balancing
cytoskeletal forces. While TCR and LFA-1 signalling cooperate
to promote cell anchorage, these experiments illustrate the
challenge in identifying the specific roles of each through
conventional approaches. As such, we used micropatterning to
spatially separate each receptor system.
We first employed a grid pattern of OKT3 lines (1 mm in
width, spaced 10 mm apart) overlaid with lines of ICAM-1
(OKT3/ICAM-1 grids), reorganizing the archetypal IS bulls eye
pattern of TCR surrounded by LFA-1 along orthogonal, linear
directions (Fig. 2A). Because ICAM-1 is sensitive to drying, we
printed fluorescently labelled anti-human Fab fragments,
blocked with bovine serum albumin and incubated with an
ICAM-1 solution. Again we tested for equal ligand densities by
using unlabelled Fab fragments and direct labelled ICAM-1
(Fig. S1B, ESI†).
Primary CD4+ T cells extended preferentially along lines of
OKT3 (Fig. 2A and B) indicating that the TCR complex promotes
anchorage of the cytoskeleton to these surfaces. The role of
ICAM-1 is seen in analysis of adhesion-free cell edges formed at
the intersections between lines. The radius of curvature, R, is
related to the extent of spreading along the grid lines as well as
the cytoskeletal tension. Interestingly, while spreading along
the OKT3 lines was unchanged and cells spread to a lesser
extent along the perpendicular ICAM-1, the free-edge radii were
significantly larger on the OKT3/ICAM-1 grids. This indicated
that addition of LFA-1 signalling to the system was enhancing
the cytoskeletal tension. This is in agreement with the idea of a
contractile cytoskeleton across the IS (which is suggested by
centripetal motion of microclusters for cells on lipid bilayers27,28)
and was also confirmed by blebbistatin treatment, which reduced
the free-edge radii on the OKT3/ICAM-1 but not the OKT3/OKT3
grids. Intriguingly, cell spreading along ICAM-1 decreased with
blebbistatin treatment, suggesting that LFA-1 function, like that
of other integrins, is reinforced by cell contractility. Notably,
blebbistatin treatment increases spreading of cells on OKT3/
ICAM-1 along OKT3 (Fig. 2B), further supporting the idea that
OKT3 is associated with cell anchorage.
To directly test the eﬀect of LFA-1 on cytoskeletal tension, we
measured cell traction forces using sub-micrometre elastomer
(polydimethylsiloxane, PDMS) pillar arrays.24,29,30 The pillars
were modified with OKT3 and ICAM-1, and the arrays were
seeded with Jurkat cells, which exhibit a similar pattern of
spreading on surfaces as primary T cell blasts2 (see also Fig. 5).
The larger, flatter lamellipodium of Jurkat cells allowed us to
measure pillar deflection by bright-field microscopy,29 which
oﬀered better accuracy than the main alternative of fluores-
cence microscopy; the noise level through random fluctuations
in position measured for fluorescent-labelled pillars not
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underlying any cells was three-fold higher than for bright-field
(data not shown). Interaction of Jurkat cells with these arrays
was similar to that with glass coverslips, consisting of an initial
phase of rapid spreading and extension of flat protrusions,
followed by stabilization of cell area over a period of several
minutes (Movies 1 and 2). In both phases, pillars undergoing
large deflections were localized to the cell edge (one to two
rows of pillars spaced 1 mm centre-to-centre). Upon initial
contact with a cell, individual pillars were initially deflected
outward, but then contracted towards the cell centre as the
membrane edge progressed across the surface (Fig. 2D and E).
The distribution of contractile forces (calculated from only
inward-deflected pillars) for cells on OKT3/ICAM-1 coated
arrays is shown in Fig. 2F. Cells on arrays coated with OKT3
alone generated significantly smaller contractile forces. LFA-1
signalling thus augments cytoskeletal contractility, supporting
the model developed using the micropatterned grids.
TCR and LFA-1 recruit diﬀerent actin assembly proteins
Seeking a molecular basis for the diﬀerent roles of TCR and
LFA-1 identified above, primary CD4+ T cell blasts on OKT3/
ICAM-1 grids were stained for proteins involved in modulation
of the actin cytoskeleton. Both Arp2/3 and HS1 (a stabilizer
of Arp2/3 branching,28,31 Fig. 3A) localized preferentially to
the OKT3 lines, consistent with a role of TCR signalling in
promoting cell anchorage and extension on these surfaces.
Inhibition of Arp2/3 with CK-666 completely abrogated cell
attachment (data not shown), illustrating the need of actin
Fig. 1 LFA-1 is necessary T cell spreading and enhances T cell activation. (A) Continuous presentation of TCR and LFA-1 ligands. 3D reconstruction of
confocal micrographs of anti-myosin IIa and phalloidin stained human CD4+ cells on OKT3 + ICAM-1 (left panel) and OKT3 (right panel); note the
dendritic vs. circular morphology of the T cells on the OKT3 vs. OKT3 + ICAM-1 substrates. (B) Phospho-tyrosine and phalloidin staining of human CD4+
cells on spin coated PDMS (50 mm thickness), coated with either OKT3 or OKT3 and ICAM-1. The mean phospho-tyrosine intensity is higher on rigid
(Sylgard 184, 2 MPa) than on soft (Sylgard 527, 5 kPa) substrates. The presence of ICAM-1 further enhances phospho-tyrosine levels. p values from one-
way ANOVA with Tukey’s multiple comparison test: p o 0.005 (**); p o 0.0001 (***); not significant (ns).
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branching/polymerization in IS formation but limiting further
exploration of the eﬀect of TCR on IS cytoskeletal dynamics; a
diﬀerent approach to this issue is described in the following
section. Complementarily to these proteins, FHOD1 (a formin
needed for the organization of lamellar actin, integrin adhesion
maturation and cell spreading32) accumulated around ICAM-1
Fig. 2 LFA-1 is necessary for the development of cell edge tension. (A) 3D reconstruction of phalloidin (blue) and myosin (green) in CD4+ T cells,
spreading on OKT3 vs. ICAM-1 and OKT3 vs. OKT3 grids (1 mm wide lines, 10 mm pitch). (B) Population analysis of bi-directional spreading lengths along
orthogonal OKT3 lines and along OKT3 vs. ICAM-1 grids in the control cells and after blebbistatin-treatment. Blebbistatin treatment decreases the
spreading length along ICAM-1 lines and increases the spreading along OKT3 lines. (C) Free-cell edge curvature radii are significantly larger on OKT3 vs.
ICAM-1 than on OKT3 vs. OKT3 grids. Blebbistatin treatment decreases the curvature radius on the OKT3 vs. ICAM-1 grids, indicating that LFA-1 regulates
cytoskeletal tension via actomyosin contractility. Error bars indicate SD. n = 121 (OKT3 vs. ICAM-1 control), 92 (OKT3 vs. ICAM-1 blebbistatin), 130 (OKT3
vs. OKT3 control) and 152 (OKT3 vs. OKT3 blebbistatin); p values from student’s t-test: po 0.05 (*); po 0.001 (**); po 0.0001 (***). (D–F) PDMS pillar
arrays. Jurkat cells were spread on PDMS pillar substrates coated with OKT3 + ICAM-1 or OKT3 and imaged with 1 frame per second from the initiation of
spreading. Addition of ICAM-1 enables cell spreading (D) and increases (contractile) inwards-directed forces. (E) Quantification of displacement angles for
all pillars over 60 s after first contact. (F) Contractile forces (vector component perpendicular to the cell edge of inwards displacements) are significantly
higher in the presence of ICAM-1. n 4 400 pillars for 5 cells per condition. Student’s t test: p o 0.0001 (***).
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adhesion lines (Fig. 3A and B). Other formin family proteins
(mDia1, mDia2, FMNL1) lacked a clear localization to TCR and
OKT3 lines (Fig. S3, ESI†), in agreement with previous studies
suggesting these do not participate in assembly of IS actin.33
Furthermore, the pan-formin inhibitor smiFH2 selectively dis-
abled spreading of T cell blasts along ICAM-1 lines, resulting in
a concurrent T cell elongation along OKT3 lines (Fig. 3C and D).
This eﬀect was thus similar to that of blebbistatin, suggesting
that formin-dependent elongation of actin fibres downstream
of LFA-1 is required for cytoskeletal tension.
Finally, FHOD1 knockdown in Jurkat cells and formin
inhibition with smiFH2 (Movies 3 and 4) reduced traction force
profiles to levels comparable to cells on OKT3 alone, further
supporting a role for FHOD1 in forming a contractile cytoskeleton
(Fig. 3E–H) and coordinating intra-IS signalling of LFA-1 and the
TCR complex.
Fig. 3 Actin assembly at TCR and LFA-1 adhesions is regulated by ARP2/3 and FHOD1, respectively (A) CD4+ T cell blasts were stained for ARP2/3, HS1,
or FHOD1. ARP2/3, as well as HS1 (quantification on the right) localize to OKT3 lines and FHOD1 is enriched at ICAM-1 lines. Quantification in (B). (C)
CD4+ T cell blasts were pre-treated with 5 mM smiFH2 and spread on OKT3/ICAM-1 grids in the presence of the drug. (D) Measurement of the T cell bi-
directional spreading lengths along orthogonal OKT3 and ICAM-1 lines. Formin inhibition disables T cell adhesion and spreading along ICAM-1 lines. n =
165 and 149 cells for control and smiFH2 treated cells respectively. (E–H) FHOD1 is needed for contractile forces. FHOD1 knockdown or treatment with
smiFH2 decreases the forces to the level observed without ICAM-1. FHOD1-shRNA transfected cells were identified by the expression of GFP under
control of a CMV promoter on the shRNA plasmid (E, inset), validation of knock down efficiency in (G). (F) Pillar displacement directions for all pillars over
60 s after first contact; (H) contractile forces (vector component perpendicular to the cell edge of inwards displacements); n4 400 pillars for 5 cells per
condition. p values from student’s t-test: p o 0.0001 (***).
Integrative Biology Paper
Op
en
 A
cc
ess
 A
rti
cle
. P
ub
lis
he
d o
n 0
3 J
uly
 20
15
. D
ow
nlo
ad
ed
 on
 09
/07
/20
15
 10
:46
:57
. 
 T
his
 ar
tic
le 
is 
lic
en
sed
 un
de
r a
 C
rea
tiv
e C
om
mo
ns
 A
ttr
ibu
tio
n 3
.0 
Un
po
rte
d L
ice
nc
e.
View Article Online
Integr. Biol. This journal is©The Royal Society of Chemistry 2015
The TCR complex provides a persistent source of actin
nucleation
The separation of receptor systems provided by the grid patterns
was eﬀective in allowing study of their independent eﬀects on the
cytoskeleton as a mechanical platform, but does not capture the
physiological configuration of the IS. As such, we examine in this
section cells on arrays of 1 mm diameter dots containing OKT3
surrounded and separated by ICAM-1 (Fig. 4 and Fig. S1C (ESI†) for
comparison of coating eﬃciencies). Within 30 min of attachment
to these surfaces, primary CD4+ T cells developed dense clusters of
actin over the OKT3 dots (Fig. 4, arrows), surrounded by continuous
actin networks over the LFA-1 adhesion area. Omission of ICAM-1
or replacing it with poly-L-lysine reduced cell–substrate interaction
to a series of small projections, reminiscent of protrusions
reported to form at the interface between T cells and anti-CD3
coated beads19 and illustrating the need to study LFA-1 and
TCR signalling together.
To investigate the dynamics of this system, we followed
spreading of primary CD4+ T cells and Jurkats expressing GFP-
labelled actin on micropatterned surfaces. In both cell types,
engagement of an OKT3 feature was immediately followed
by F-actin polymerization (Fig. 5A, kymographs, white arrows;
Movies 5 and 6) and acceleration of actin network extension,
focused around these sites of TCR activation (note spreading
acceleration on red dS/dt plots, asterisks). As a result, F-actin
was highly concentrated at the OKT3 dots (Fig. 5B). This
process repeated as the cell encountered new OKT3 features.
Notably, actin polymerization occurred not only at OKT3
features along the cell edge, but also on those located within
the central area of the cell–substrate interface. In addition,
these internal features were frequently associated with rotating
vortices of actin unfolding from the sites of TCR engagement
(Fig. 5C, Movie 7), indicating that the polymerization was
outpacing the transport of actin away from the nucleation site.
Since the spreading and bifurcation process was similar
between both cell types we focused on Jurkat cells, which were
stably transfected with GFP-actin, enabling a thorough analysis
of actin dynamics by fluorescence recovery after photobleach-
ing (FRAP) (Fig. 5D).
Thereby, we detected further diﬀerences in actin dynamics
around TCR and LFA-1. Post-bleach recovery of GFP-actin
fluorescence over OKT3 dots was faster than over ICAM-1 areas
Fig. 4 TCR-nucleated actin cluster are transformed into a continuous network by LFA-1. 3D reconstructions of the human CD4+ T cells on
micropatterned surfaces of OKT3 dots on ICAM-1 background, BSA-blocked glass without ligands, or poly-L-lysine (PL) (1 mm dots, 5 mm pitch).
CD4+ T cells spread out over multiple OKT3 dots on ICAM-1 background. Without ICAM-1 (uncoated glass) or when substituted with poly-L-lysine (PL)
spreading was suppressed, and cells formed thin projections that connected to the OKT3 dots.
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Fig. 5 TCR and LFA-1 promote actin assembly by diﬀerent mechanisms. (A) GFP-actin dynamics in primary human CD4+ (upper panels) and Jurkat
T lymphocytes (lower panels) on OKT3-dotted ICAM-1 substrates (1 mmOKT3 dots, 5 mm pitch). From left to right – single capture of cell at the moment
of spreading bifurcation (white arrow), time average density diagram, kymographs of the white line on the left panels showing OKT3 dot-induced
bifurcation, T cell spreading area (black lines) and derivative plots (red). Sub-stable cell spreading areas – black asterisks, spreading bifurcations – black
arrows, cell spreading acceleration peaks – red asterisks. (B) Actin-GFP density profile average (n = 17) across OKT3 dot and surrounding ICAM-1 area. (C)
F-actin polymerization spiral unfolding from a nucleating TCR adhesion site in a Jurkat cell. Right panel: Kymograph and corresponding actin-GFP (black
curve) and OKT3 dot (red curve) density profiles along the indicated line. (D–F) FRAP analysis of stable transfected GFP-actin Jurkat cells. (D) GFP-actin
bleach areas and kymograph of recovery (right panels, asterisks mark the bleach event); (E) actin-GFP fluorescence recovery curves over OKT3 dot (top
panel) and ICAM-1 adhesion areas (bottom panel) for control cells and CK-666 or smiFH2 treated cells. (F) Actin-GFP semi-recovery times (mean
and standard deviation in red). Because of the lack of fluorescence recovery, curves could not be fitted for CK-666 treated cells. p values from student’s
t-test: p o 0.001 (**); p o 0.0001 (***); not significant (ns).
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(half-time to full recovery, t1/2 = 7.4 s vs. 12.4 s, see Fig. 5E and F),
suggesting that the site of TCR engagement promotes actin
polymerization and turnover. Both recovery rates were slower
than that predicted by free-diﬀusion (t1/2 of o0.074 s for
reported G-actin diﬀusion rates of43 mm2 s!1),34–37 indicating
that actin assembly is regulated in both systems. The slower
recovery over the ICAM-1 than over the OKT3 areas was con-
sistent with the observations of higher actin polymerization
over the OKT3 dots.
Since our analysis of the molecular components indicated
that the actin nucleator Arp2/3 was mainly localized to the TCR,
while the actin elongation and bundling protein FHOD1 was
enriched at the LFA-1 lines, we hypothesized that Arp2/3
dependent actin nucleation at TCR sites drives the FHOD1
dependent network extension downstream of LFA-1. To inves-
tigate this, we turned again to FRAP experiments, using small
molecule inhibitors of Arp2/3 and formins.
Indeed, inhibition of Arp2/3 actin nucleation with CK-666
blocked recovery over both OKT3 and ICAM-1-presenting areas
(note: in this experimental setup the cells were already spread out
at the timepoint of CK-666 treatment – unlike the pre-treatment
with CK-666 above, which blocked cell attachment). In contrast,
smiFH2 treatment mainly reduced the recovery over the LFA-1
area, while the effect on the TCR-based FRAP recovery curve was
only small (Fig. 5E). Together, these results support the model
that cytoskeletal polymerization at sites of TCR engagement
acts as a structural primer feeding growth of lamellipodia
structures, which requires LFA-1 signalling.
Cytoskeletal contraction activated the TCR complex
As a counterpart to the eﬀects of TCR and LFA-1 on cytoskeletal
mechanics, this section focuses onmodulation of cell signalling by
actin contractility. Blebbistatin-based inhibition of myosin func-
tion suppressed actin turnover and polymerization in cells on
patterns of OKT3 dots surrounded by ICAM-1 (Fig. 6A), indicating
that these functions of the TCR complex can be initiated through
mechanical forces generated by the cytoskeleton.
To test this hypothesis, we treated the cells with calyculin A to
increase myosin contractility.38,39 The hypercontractility resulted
in a rounding of the cells, which was previously reported in other
cell types as well.38,40 In our system however, the collapse of the
cell–substrate interface was accompanied by formation of retrac-
tion tethers between the cell body and the OKT3 dots (Fig. 6B).
The change in cell morphology did not allow us to directly assess
a potential influence of the contractility on the mechano-
regulation of TCR actin assembly. However, the strong actin
polymerization continued at the sites of OKT3 even after retrac-
tion of the cell body (Fig. 6B, kymographs: arrowheads; Movie 8),
further supporting the dual roles of the TCR complex as both a
point of cell anchorage and sites of actin polymerization.
As an alternative approach to test the eﬀect of cytoskeletal
contractility at the cellular level, we employed more extensive
patterns of OKT3 consisting of stars, tridents, and spindles,
surrounded by ICAM-1. Such adhesive features were previously
demonstrated to concentrate mechanical tension at their
apices in other cellular systems20,33
Indeed, CD4+ T cells formed dense F-actin clusters prefer-
entially at the apices of these shapes (Fig. 6C), suggesting a
tension sensitivity of TCR actin assembly. This was indepen-
dent from the distance to the cell edge, excluding an enhance-
ment of actin assembly due to the proximity to the cell
periphery (Fig. 6C, star pattern). Live imaging showed repeated
F-actin polymerization bursts at the apices and the concomi-
tant propagation of the actin waves (Fig. 6D, Movie 9). Together,
these results pose a provocative loop through which TCR
signalling serves to sustain its own activity by promoting
assembly and ultimately (together with LFA-1) contraction of
the cytoskeleton.
Discussion
Mechanical forces are increasingly recognized as regulators
of many cellular functions.41 In these processes, stimuli such
as extracellular shear stress and/or intracellular actomyosin
contractility are translated into downstream signals through
mechanosensitive proteins.42 This has been studied predomi-
nantly in the context of interaction of adherent cells to an ECM
matrix, in which integrins or linker proteins undergo force
dependent conformational changes and display a catch bond
behaviour, but more recently other cell surface receptors
including N-cadherin, Netrin or the dystrophin–glycoprotein
complex (DGC) have been suggested asmechanotransducers,43–46
expanding the range of physiological functions that are recog-
nized to be influenced by mechanobiology. The identification
of mechanosensing in T cells represents a new frontier that
spans from fundamental principles of molecular biophysics
to improving immunotherapy and treatment of disease.15
However, understanding these effects in the T cell system is
challenging as signalling downstream of the TCR is tightly
dependent on and interconnected with a wide array of additional
cell surface receptors such as LFA-1 and CD28. Initial studies
demonstrating an impact of mechanical forces on the TCR
complex focused on this receptor alone,6,47,48 and were thus
limited to comparatively early events. More recent studies have
begun to integrate TCR and CD28 in the context of cellular
mechanics. In particular, the ability of T cells to modulate
activation in response to the rigidity of a substrate presenting
antibodies to CD3 and CD28 is associated predominantly with
the TCR complex.14 It was subsequently shown that CD28
co-stimulation increases cellular force generation on TCR adhe-
sions.49 These results are consistent with the observation that
soluble anti-CD28 is effective in stimulating T cells. Signalling
by the integrin receptor LFA-1, in support of TCR, is anticipated
to be more complicated, since both systems support cell
spreading as illustrated throughout this report; previous stu-
dies using beads showed that LFA-1 signalling causes an early
initiation of pulling forces following TCR activation.19 This
transformation of polymerization-based forces into contractile
forces agrees well with our current study. While, Husson et al.
did not find a change in the magnitude of the pulling forces,
compared to beads coated with OKT3 alone, this might have
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been masked by the higher probe stiffness (50 pN mm!1 vs.
8.4 pN mm!1 for the pillars) and the spatial resolution of this
assay. Similarly, LFA-1 alone led to a restricted pulling phase
in the aspiration assays, but this data was limited by the
co-presentation challenge discussed above.19
In this study, we used surface micropatterning to dissect the
eﬀects of TCR and LFA-1, while maintaining stable attachment
at the cellular level. We found that these systems serve diﬀerent
functions, namely that actin nucleation at sites of TCR activa-
tion lead to a sustained LFA-1 dependent actin network growth.
Fig. 6 Myosin contractility modulates TCR activity. (A) Examination of actin-GFP expressing Jurkat cells shows a reduction of actin polymerization after
blebbistatin treatment. Top panel: Image taken immediately after bleaching; middle panel: actin density kymograph, starting after the bleach event
(blebb: time point of blebbistatin addition); lower panel: actin density profiles at the time points indicated in the kymograph. (B) Calyculin A (ClcA) hyper-
contractility-driven cell collapse is accompanied by formation of TCR-anchored retraction tethers. Note the continuous actin polymerization events
(arrowheads) at TCR adhesions inside the retraction tether (white line). Addition of ClcA is marked on the kymograph. (C and D) Introduction of spatial
anisotropy demonstrates the mechanosensitive nature of TCR. (C) Immunofluorescence analysis of CD4+ primary T cells: F-actin cluster formation at the
apices of multi-apical OKT3 adhesions sites within ICAM-1 field. (D) Live cell imaging of CD4+: actin-GFP forms apical clusters with periodic density
bursts (arrows) that consequently ignite F-actin polymerization waves (combs). Time average actin density map shows all three clusters at the tri-dent
OKT3 adhesion patch. Note the apical actin periodic density bursts indicated in the kymograph.
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The actin network, in response, enhances the cytoskeletal tension
and the sensitivity to mechanical signals such as substrate
rigidity. In line with previous studies2,50 our data suggests that
on anti-CD3 coated substrates the contribution of myosin to the
cellular forces and cell morphology is rather limited.
While the activation of early T cell signalling, measured
here by total phospho-tyrosine levels, is still responding to
substrate rigidity in the absence of LFA-1, this response is
enhanced in its presence. Because the levels of actin assembly
downstream of the TCR depend on myosin activity, we propose
that it is the LFA-1 dependent increase in cytoskeletal forces
that lead in turn to an enhanced TCR signalling on compliant
substrates.
This separation of functions also extends to separation of
actin assembly pathways, namely Arp2/3 dependent actin nuclea-
tion at the TCR and FHOD1 dependent network extension
downstream of LFA-1. The diﬀerent actin regulation by TCR
and LFA-1 was clearly visible in dynamic spreading studies on
the OKT3 dots, as well as the FRAP experiments. We attribute the
particular actin-GFP recovery dynamics mainly to the diﬀerent
rates of nucleation or elongation of the respective assembly
factors that associated with the receptors (i.e. Arp2/3 or FHOD1).
In presence of a nucleation promotion factor (NPF), Arp2/3
strongly enhances actin nucleation,51 while the rate of actin
incorporation into new or existing filaments is in fact lower in
the presence of FHOD1 than in presence of actin alone.51,52
Additionally, Arp2/3 forms dendritic networks that are growing
in three-dimensions (as can be seen with the actin clusters over
the OKT3 dots in Fig. 4, and which has also been found in
previous in vitro studies53), while in contrast FHOD1 has a strong
actin bundling activity and forms linear actin structures that
oﬀer the bleached GFP-actin fewer degrees of freedom to exit the
region of interest.32,52
A study that was published while this manuscript was
under review found that the NPF WASp was responsible for
the formation of dense actin foci at TCR microclusters on OKT3
and ICAM-1 functionalized coverslips and supported lipid
bilayers that accounted for approx. 10% of the total actin.54
Silencing of the WASp pathway inhibited HS-1 recruitment and
resulted in the loss of the actin foci. The presence of the
same molecules (Arp2/3, HS-1) indicates that these foci corre-
spond to the dense clusters that we find localized to the contact
printed OKT3 areas. However, while we find that inhibition of
Arp2/3 aﬀects assembly of actin over of both OKT3 and ICAM-1
areas, the overall F-actin concentration is reportedly unchanged
in absence of WASp activity.54,55 This suggests that diﬀerent
sources of actin assembly are localized to the periphery or the
cortex of the cell, where we did not probe the actin dynamics.
Indeed other NPFs, such as Scar/WAVE localize to the tip of
lamellipodia in lymphocytes and other cells and could compen-
sate for the loss of WASp.56,57 Interestingly, such compensation
of actin nucleation – in combination with the mechanical
anchoring function of the TCR, seen on our patterned surfaces
may also explain the phenomenon of symmetry breaking, found
in WASp deficient cells.56,57 WASp at the mechanically anchored
TCR would allow to establish a symmetric immune synapse,58,59
which is lost after re-balancing towards other NPFs, such as Scar/
WAVE at the cell periphery, – leading to symmetry breaking.
Finally, our results show that the mechanical cooperative
systems react to force in several ways: (1) LFA-1 adhesions are
mechanosensitive and require force for stabilization. (2) Actin
nucleation at the TCR is enhanced by cytoskeletal tension,
which (3) is regulated downstream of LFA-1. Together, our data
clarifies the distinct roles of TCR and LFA-1 signalling in the
regulation of the T cell–APC interaction as well as in the force
dependent T cell activation.
Materials and methods
Cell culture and transfections
Primary human CD4+ T cells were freshly isolated from the
donor’s blood samples using established techniques. Whole
blood was diluted with cold RPMI in 1 : 1 proportion and then
sedimented through Ficoll layer (Ficoll-Paque PLUS, General
Electric) at 800 g for 30 minutes. White blood cells were
collected from the sediment atop of Ficoll layer and subjected
to CD4+ T cells purification using Dynabeads Untouched
Human CD4 T Cells kit (Invitrogen).
For activation, RosetteSep-purified CD4+ human T cells were
seeded in 24-well plates coated with anti-CD3 and anti-CD28
antibodies at a concentration of 1 " 106 cells per ml in complete
RPMImedium and incubated at 37 degrees for 72 hours. At 72 hours
blasted cells were diluted to 1 " 106 cells per ml, transferred
to non-coated tissue culture flasks, and incubated for an
additional 48 hours before freezing for long-term storage.
Stably transfected actin-GFP Jurkat cells were a kind gift from
Prof. Daniel Billadeau. Cells were transfected with the indicated
plasmids using Amaxa nucleofection, according to the manu-
facturer’s protocol.
Substrate preparation and micropatterning
Microcontact printing was performed as described elsewhere.22
Briefly, hPDMS stamps were cast on Ebeam-lithographed PMMA
wafers. 20 mg ml!1 ligand proteins in PBS were deposited onto the
stamps for 40 min. Micro-patterns were printed by stamping
on plasma-treated glass for 1 min. OKT3/ICAM-1 micro-grids were
printed in two steps: (1) fluorescent OKT3 lines deposition
(BioLegend) followed by (2) printing of transverse fluorescent
anti-human Fab lines (Jackson Inc. second lines set). After follow-
ing 5% BSA (Sigma) blocking for 40 min the micro-patterns were
incubated with 40 mg ml!1 solution of the hICAM-1/CD54
Fc chimera protein (R&D systems). OKT3/OKT3 grids were
incubated and blocked in the same conditions to estimate
the eﬀect of non-specific ICAM-1 adsorption to the substrates.
OKT3-dotted surfaces were prepared by fluorescent OKT3
deposition as described above for the lines, followed by incuba-
tion with ICAM-1 (10 mg ml!1) or 0.1 mg ml!1 poly-L-lysin
(Advanced BioMatrix) for 1 hour.
For direct labelling of antibodies to compare coating eﬃ-
ciencies (Fig. S1, ESI†), 10 ml of a 1 M sodium bicarbonate
buﬀer at pH 8.3 were added to 100 ml of a 400 mg ml!1 solution
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of OKT3 or ICAM-1 in PBS and incubated with 10 ml of Atto
565 NHS ester (2 mg ml!1 in DMSO, Santa Cruz Biotechnology)
for 1 hour at RT with continuous agitation before dialysis against
PBS usingMicro Float-A-Lyzer devices with a 100 kDa cut-oﬀ. The
antibodies were used for coating and micropatterning at the
concentrations specified above.
PDMS pillar (500 nm diameter, 1.3 mm height, 1 mm centre-
to-centre) substrates were prepared and nanopillar assays were
performed as described previously.32 Briefly, PDMS (Sylgard
184, Dow Corning) was mixed thoroughly with its curing agent
(10 : 1), degassed, poured over the silicon mold, placed upside-
down on a plasma-treated coverslip-dish (Mattek) and cured at
70 1C for 12 h. The mold was then peeled oﬀ and the pillars
were incubated with a solution of the ligands (10 mg ml!1 OKT3
#10 mg ml!1 ICAM-1) for 1 h in PBS.
Flat PDMS substrates were prepared by spin-coating Sylgard
184 or Sylgard 527 with a 150i spin processor (SPS), onto cover-
slips at 1000 rpm for 100 s and curing at 70 1C for 12 h. Before
spin coating, Sylgard 527 was pre-cured at 70 1C for 30 minutes
with intermitted mixing to achieve a comparable viscosity to
the Sylgard 184 mixture. After curing a film thickness of 51.4 #
2.2 mm (Mean # SD) for Sylgard 184 and 52.6 # 6.7 mm for
Sylgard 527 was measured at a DektakXT Surface Profiler at the
London Centre for Nanotechnology.
Live imaging and FRAP
Briefly, the harvested cells were resuspended in the pre-warmed
(37 1C) and CO2-preconditioned media (phenol red-free RPMI-
1640 and 25 mM Hepes) and placed into the glass-bottomed
micro-printed chambers (LabTek). Live cell imaging was per-
formed on an Axiovert 200 (Zeiss) microscope, equipped with
an UltraView ERS-6 spinning-disk confocal imaging system
(PerkinElmer) and an environmental chamber (Solent Scientific),
using a ORCA-ER camera (Hamamatsu Photonics) and Volocity
software (v5.5; PerkinElmer) at the Children’s Hospital of
Philadelphia. FRAP was performed as described elsewhere.2
Spreading assays, nanopillar assays and pharmacological
treatments
T cell spreading assay was performed at 1 " 106 cells
per ml concentration. Cells treatment with non-enantiomeric
(!)-blebbistatin (Sigma) was performed in two diﬀerent
manners: for immunofluorescent analysis the treatment was
continuous throughout pretreatment to the cell spreading stages:
15 minutes prior to the cells plating samples were resuspended
in 100 mMblebbistatin solution in supplemented complete RPMI
media and incubated on micro-chips. For live cell imaging of
acto-myosin inhibition, blebbistatin was added at the moment
of interest to its final concentration of 100 mM. Calyculin A (Cell
Signaling Technology, Inc.), was added to the working concen-
tration of 50 nM at the moment of interest. For formin and
ARP2/3 inhibition experiments, cells were treated with 5 mM
smiFH2 and 50 mM CK-666, respectively (both Sigma) for
15 minutes prior to cell plating and spread in presence of the
drugs. For FRAP experiments, smiFH2 and ARP2/3 were added
30 minutes after plating and cells were imaged immediately
after drug addition. Immunofluorescence staining was per-
formed as described previously.60
Antibodies and plasmids
The rabbit anti-non-muscle Myosin IIa, anti-mDia1 and anti-
FMNL1 antibodies were obtained from Abcam, rabbit anti-
FHOD1 and polyclonal goat anti ARP2/3 subunit 1b antibodies
antibodies were from Sigma and rabbit anti pHS1 was from Cell
Signaling Technology. Alexa Fluor 647 anti-Phosphotyrosine
Antibody [Clone: PY20] was from Biolegend. Polyclonal rabbit
anti-mDia2 was purchased from ECM Bioscience. Alexa-568 or
647-conjugated phalloidin was from Life technologies. HRP-
conjugated anti mouse, anti-rabbit and anti-goat antibodies,
DyLight 488, cy3, Alexa 647 or DyLight649 conjugated anti-
rabbit, or anti-mouse antibodies were obtained from Jackson
ImmunoResearch.
Statistical testing
In the current study, two-tailed Student’s t-test was used for
comparison between two groups. Data sets were tested for normal
distribution using the Shapiro–Wilk test. All statistical tests and
curve fitting (FRAP) was performed with Graphpad Prism.
Image processing
Original digital images obtained were assembled to the figures and
labelled using Illustrator (Adobe). Only linear contrast adjustments
were used and were always applied to the entire image.
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